Last quarter (Q ), Phasebio Pharmaceuticals's total revenue was $208.00K, a decrease of -97.99% from the same quarter last year. In Q, Phasebio Pharmaceuticals's net income was $-16.66M. See Phasebio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ 818.00K	$ 10.83M	$ 0.00	$ 2.36M	$ 668.00K	$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	$ 105.02M	$ 118.19M	$ 84.86M	$ 42.10M	$ 20.31M	$ 8.54M
Operating Income	$ -104.20M	$ -107.36M	$ -84.86M	$ -39.74M	$ -19.64M	$ -8.54M
Net Non Operating Interest Income Expense	$ -645.00K	$ -933.00K	$ -1.21M	$ 506.00K	$ -3.54M	$ -2.67M
Other Income Expense	$ 2.01M	$ -21.18M	$ -12.50M	$ -17.00K	$ -665.00K	$ 962.00K
Pretax Income	$ -102.84M	$ -129.47M	$ -98.56M	$ -39.25M	$ -23.85M	$ -10.25M
Tax Provision	-	$ 1.60M	$ 0.00	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -102.84M	$ -131.07M	$ -98.56M	$ -39.25M	$ -23.85M	$ -10.25M
Basic EPS	$ -2.13	$ -2.98	$ -3.39	$ -1.43	$ -4.49	$ -13.78
Diluted EPS	$ -2.13	$ -2.98	$ -3.39	$ -1.43	$ -4.49	$ -13.78
Basic Average Shares	$ 194.04M	$ 43.92M	$ 29.06M	$ 27.49M	$ 5.31M	$ 743.47K
Diluted Average Shares	$ 194.04M	$ 43.92M	$ 29.06M	$ 27.49M	$ 5.31M	$ 743.47K
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 105.02M	$ 118.19M	$ 84.86M	$ 42.10M	$ 20.31M	$ 8.54M
Net Income From Continuing And Discontinued Operation	$ -102.84M	$ -131.07M	$ -98.56M	$ -39.25M	$ -23.85M	$ -10.25M
Normalized Income	$ -104.85M	$ -115.61M	$ -86.06M	$ -39.23M	$ -23.18M	$ -11.21M
Interest Expense	$ 672.00K	$ 947.00K	$ 1.45M	$ 1.08M	$ 3.92M	$ 2.72M
EBIT	$ -102.17M	$ -128.52M	$ -97.12M	$ -38.17M	$ -19.92M	$ -7.52M
EBITDA	$ -100.23M	$ -126.73M	$ -96.61M	$ -38.00M	$ -19.82M	$ -7.43M

Currency in USD

Phasebio Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing